Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 160,890 | 102,717 | 69,141 | 94,770 | 85,297 |
| Cost of Goods | 10,098 | 5,649 | 3,126 | 3,334 | 3,594 |
| Gross Profit | 150,792 | 97,068 | 66,015 | 91,436 | 81,703 |
| Operating Expenses | 300,762 | 252,524 | 330,668 | 239,728 | 197,398 |
| Operating Income | -149,872 | -154,807 | -264,527 | -147,958 | -115,101 |
| Interest Expense | 17,326 | 18,317 | 17,298 | 17,684 | 19,318 |
| Other Income | -36,219 | 6,877 | 15,412 | 28,684 | 54,190 |
| Pre-tax Income | -203,417 | -166,247 | -266,413 | -136,958 | -80,229 |
| Net Income Continuous | -203,417 | -166,247 | -266,413 | -136,958 | -80,229 |
| Net Income Discontinuous | N/A | N/A | 69,646 | 28,337 | 22,148 |
| Net Income | $-203,417 | $-166,247 | $-196,767 | $-108,621 | $-66,233 |
| EPS Basic Total Ops | -2.28 | -2.12 | -2.56 | -1.43 | -0.89 |
| EPS Basic Continuous Ops | -2.28 | -2.12 | -3.46 | -1.81 | -1.08 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.90 | 0.38 | 0.30 |
| EPS Diluted Total Ops | -2.28 | -2.12 | -2.56 | -1.43 | -0.89 |
| EPS Diluted Continuous Ops | -2.28 | -2.12 | -3.46 | -1.81 | -1.08 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.90 | 0.38 | 0.30 |
| EBITDA(a) | $-122,583 | $-125,167 | $-241,089 | $-123,053 | $-97,299 |